Wara Samar
19th May 2025
Meridian Health Ventures Launches €44.7M Transatlantic Fund to Bridge UK and US HealthTech Growth
Meridian Health Ventures – previously KHP Ventures – has announced the launch of a new transatlantic venture capital fund, securing Limited Partner commitments totalling approximately €44.7 million. This milestone fund is designed to back HealthTech superscalers with strong potential to grow both within the UK’s NHS and across the US healthcare market.
Founded in 2021, Meridian Health Ventures is the first NHS-anchored VC fund with a dual-Atlantic strategy, investing in clinically grounded technologies with global applications. The firm is led by General Partners Daniel Dickens, Dr. Nadine Hachach-Haram, Tim Irish and Dr. Pooja Sikka – a team combining experience as clinicians, investors, entrepreneurs, and operators. Their shared mission: support scalable innovations without losing UK-grown talent and impact to overseas markets.
“With this Fund, we want to supercharge the growth of the most promising innovations so they can deliver direct benefits to the NHS’s patients and workforce, as well as the wider UK economy,” said Dr. Nadine Hachach-Haram, in a statement. “Through transatlantic collaboration, we are also creating an environment where ambitious founders can scale at pace – both domestically and internationally – bridging the gap between UK NHS and US healthcare systems for a start.”
Backing Founders, Fueling Impact
Meridian’s portfolio already includes some of the UK’s fastest-growing HealthTech companies such as Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout. These companies have collectively deployed solutions in over 100 NHS Trusts and are increasingly expanding their footprint to major US healthcare providers, including Cedars-Sinai.
Twelve NHS Clinical Entrepreneurs are among the founding teams in the fund’s portfolio, further anchoring innovation in the realities of frontline care. The firm has also tapped into talent emerging from top UK institutions like Oxford, Cambridge, King’s College, Imperial, and Southampton.
Daniel Dickens, Co-Managing Partner at Meridian Health Ventures, emphasised the importance of scaling innovations within the UK: “As Founders ourselves, we’ve launched this Fund to ensure that the next generation of HealthTech breakthroughs can be scaled in the UK, not just invented here. We’re proud to partner with this group of leading health systems and healthcare investors on both sides of the Atlantic, and of course to work with the driven and talented founding teams in the Fund’s portfolio.”
The fund is anchored by prominent institutions including Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital, University College London Hospitals, and Cedars-Sinai Medical Center. Hartford HealthCare is also expected to join soon, signalling further transatlantic momentum.
A New Model for Global Growth
This fund isn’t the firm’s only step into thematic investing. In October 2024, it launched Europe’s first dedicated mental health tech fund, the Innovations in Mental Health (IMH) Fund, backed by the Wellcome Trust and in partnership with South London and Maudsley NHS Foundation Trust. Together with the new transatlantic fund, these initiatives represent a €44.7 million commitment to transformative care.
For Cedars-Sinai, a long-time collaborator with the Meridian team, the alignment is strategic. James D. Laur, JD, Chief Intellectual Property Officer at Cedars-Sinai and Managing Director of Cedars-Sinai Health Ventures, said: “Our mission is to provide patients around the world with the best care possible. We have been impressed by the quality and depth of the HealthTech Founders in their portfolio and are excited to build on our collaboration as Partners in the Fund.”
By enabling ambitious HealthTech startups to scale both within the UK and internationally, Meridian Health Ventures is addressing a key challenge: ensuring homegrown solutions can grow without leaving the ecosystem that birthed them.
The new transatlantic fund isn’t just about capital – it’s about capability, credibility and collaboration. In doing so, it may help reframe the trajectory for the UK’s most promising clinical innovators.
MedTech World Bay Area
MedTech World Bay Area will take place on June 26–27, 2025, in collaboration with MedTech Innovator. The event offers a focused setting for sponsors and investors to connect directly with 100 fundraising startups and key stakeholders in medical technology. Across the two days, attendees can expect practical discussions and targeted networking, including panels such as ‘What Investors Want in 2025: New Rules of MedTech Fundraising’ and ‘Regulatory to Revenue: Building with the End in Mind’. For information on sponsorship or to reserve your place, contact us at [email protected].
